Vaxphoid
Rx25 mcg/0.5 ml • IM Injection
ইঙ্গিত ও ব্যবহার
Vaxphoid এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Dosage: Adults and children aged 2 years or older receive a single 0.5 ml dose. For those who remain at risk of typhoid fever, a single booster dose is recommended, given no more than 3 years after the previous dose. Administration: Typhoid Polysaccharide Vaccine is given by intramuscular injection only and must never be administered intravenously. In adults, the injection is given in the deltoid muscle; in children, it may be given in either the deltoid or the vastus lateralis muscle. It should not be injected into the gluteal region, as a nerve trunk may be present there. Because bleeding can occur at the injection site, the vaccine should be given with caution to people with thrombocytopenia or other bleeding disorders. After the injection, firm pressure (without rubbing) should be applied to the site for at least two minutes. Co-administration: This vaccine may be given at the same time as other vaccines, but it must not be mixed with any other vaccine or medicinal product in the same syringe.
পার্শ্বপ্রতিক্রিয়া
Most people who receive the Typhim Vi vaccine experience some reaction to it, usually mild to moderate and short-lived. The most common are local reactions at the injection site, such as redness, swelling, and tenderness. Systemic reactions such as general discomfort, headache, diarrhea, vomiting, muscle aches, and mild fever are reported less often. In very rare cases, allergic-type reactions such as itching, rash, or hives may occur.
সতর্কতা ও নিষেধাজ্ঞা
নিষেধাজ্ঞা
This vaccine helps protect against typhoid fever caused by Salmonella typhi, but it does not protect against paratyphoid fever or illness caused by non-invasive Salmonella strains. It should not be given to anyone with a known hypersensitivity to any of its components, or to anyone who has previously shown signs of hypersensitivity after receiving a typhoid vaccine or any other vaccine containing Vi polysaccharide Salmonella typhi antigens. Patients who are on immunosuppressive treatment or who have an immunodeficiency may not develop an adequate response to the vaccine. Vaccination should be postponed in anyone suffering from an acute, severe febrile illness.